SpectraBase Spectrum ID |
8JlEAs6m51E |
Name |
Phenmetrazine II |
Classification |
Pharmaceutical drug, anorectic |
Comments |
Spectrum verified by independent measurements in external laboratories |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.12 (d) (3) |
DEA Controlled Substance Name |
Phenmetrazine |
DEA Controlled Substance Type |
Salts |
DEA Controlled Substances Code Number |
1631 |
DEA Schedule |
Schedule II |
DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system |
Exact Mass |
177.115364106 u |
Formula |
C11H15NO |
InChI |
InChI=1S/C11H15NO/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10/h2-6,9,11-12H,7-8H2,1H3/t9-,11-/m1/s1 |
InChIKey |
OOBHFESNSZDWIU-MWLCHTKSSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
177.247 g/mol |
Nominal Mass |
177 u |
Quality |
986 |
Retention Index |
1431 |
SMILES |
[C@]1([C@](NCCO1)(C)[H])(C=1C=CC=CC1)[H] |
SPLASH |
splash10-05fu-9000000000-aeab5ff8a67777cf44d9 |
Sample Comments |
Stereo configuration unknown |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
Dex-phenmetrazin
Fenmetralin
Fenmetrazin
Oxazimedrin
Phenmetralin
3-Methyl-2-phenyl-morpholine |
Technique |
GC/MS |
Wiley ID |
DD2024_011097 |